These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36831541)

  • 21. Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research.
    Hendry S; Salgado R; Gevaert T; Russell PA; John T; Thapa B; Christie M; van de Vijver K; Estrada MV; Gonzalez-Ericsson PI; Sanders M; Solomon B; Solinas C; Van den Eynden GGGM; Allory Y; Preusser M; Hainfellner J; Pruneri G; Vingiani A; Demaria S; Symmans F; Nuciforo P; Comerma L; Thompson EA; Lakhani S; Kim SR; Schnitt S; Colpaert C; Sotiriou C; Scherer SJ; Ignatiadis M; Badve S; Pierce RH; Viale G; Sirtaine N; Penault-Llorca F; Sugie T; Fineberg S; Paik S; Srinivasan A; Richardson A; Wang Y; Chmielik E; Brock J; Johnson DB; Balko J; Wienert S; Bossuyt V; Michiels S; Ternes N; Burchardi N; Luen SJ; Savas P; Klauschen F; Watson PH; Nelson BH; Criscitiello C; O'Toole S; Larsimont D; de Wind R; Curigliano G; André F; Lacroix-Triki M; van de Vijver M; Rojo F; Floris G; Bedri S; Sparano J; Rimm D; Nielsen T; Kos Z; Hewitt S; Singh B; Farshid G; Loibl S; Allison KH; Tung N; Adams S; Willard-Gallo K; Horlings HM; Gandhi L; Moreira A; Hirsch F; Dieci MV; Urbanowicz M; Brcic I; Korski K; Gaire F; Koeppen H; Lo A; Giltnane J; Rebelatto MC; Steele KE; Zha J; Emancipator K; Juco JW; Denkert C; Reis-Filho J; Loi S; Fox SB
    Adv Anat Pathol; 2017 Sep; 24(5):235-251. PubMed ID: 28777142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer.
    Hida AI; Watanabe T; Sagara Y; Kashiwaba M; Sagara Y; Aogi K; Ohi Y; Tanimoto A
    Breast Cancer Res Treat; 2019 Nov; 178(2):283-294. PubMed ID: 31402409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour infiltrating lymphocytes in oropharyngeal carcinoma: prognostic value and evaluation of a standardised method.
    De Keukeleire SJ; Vermassen T; De Meulenaere A; Deron P; Huvenne W; Duprez F; Creytens D; Van Dorpe J; Rottey S; Ferdinande L
    Pathology; 2021 Dec; 53(7):836-843. PubMed ID: 34217516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition.
    Loi S; Michiels S; Adams S; Loibl S; Budczies J; Denkert C; Salgado R
    Ann Oncol; 2021 Oct; 32(10):1236-1244. PubMed ID: 34311075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
    Denkert C; von Minckwitz G; Darb-Esfahani S; Lederer B; Heppner BI; Weber KE; Budczies J; Huober J; Klauschen F; Furlanetto J; Schmitt WD; Blohmer JU; Karn T; Pfitzner BM; Kümmel S; Engels K; Schneeweiss A; Hartmann A; Noske A; Fasching PA; Jackisch C; van Mackelenbergh M; Sinn P; Schem C; Hanusch C; Untch M; Loibl S
    Lancet Oncol; 2018 Jan; 19(1):40-50. PubMed ID: 29233559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automated Detection and Scoring of Tumor-Infiltrating Lymphocytes in Breast Cancer Histopathology Slides.
    Yosofvand M; Khan SY; Dhakal R; Nejat A; Moustaid-Moussa N; Rahman RL; Moussa H
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
    Dieci MV; Radosevic-Robin N; Fineberg S; van den Eynden G; Ternes N; Penault-Llorca F; Pruneri G; D'Alfonso TM; Demaria S; Castaneda C; Sanchez J; Badve S; Michiels S; Bossuyt V; Rojo F; Singh B; Nielsen T; Viale G; Kim SR; Hewitt S; Wienert S; Loibl S; Rimm D; Symmans F; Denkert C; Adams S; Loi S; Salgado R;
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):16-25. PubMed ID: 29024776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast Cancer.
    Perez EA; Ballman KV; Tenner KS; Thompson EA; Badve SS; Bailey H; Baehner FL
    JAMA Oncol; 2016 Jan; 2(1):56-64. PubMed ID: 26469139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histologic classification of tumor-infiltrating lymphocytes in primary cutaneous malignant melanoma. A study of interobserver agreement.
    Busam KJ; Antonescu CR; Marghoob AA; Nehal KS; Sachs DL; Shia J; Berwick M
    Am J Clin Pathol; 2001 Jun; 115(6):856-60. PubMed ID: 11392882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer Patients.
    Schüler K; Bethmann D; Kaufhold S; Hartung C; Stückrath K; Lantzsch T; Uleer C; Hanf V; Peschel S; John J; Pöhler M; Buchmann J; Bürrig KF; Weigert E; Thomssen C; Kantelhardt EJ; Vetter M
    Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG trial.
    Skriver SK; Jensen MB; Knoop AS; Ejlertsen B; Laenkholm AV
    Breast Cancer Res; 2020 May; 22(1):46. PubMed ID: 32410705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy.
    de Boo L; Cimino-Mathews A; Lubeck Y; Daletzakis A; Opdam M; Sanders J; Hooijberg E; van Rossum A; Loncova Z; Rieder D; Trajanoski Z; Vollebergh M; Sobral-Leite M; van de Vijver K; Broeks A; van der Wiel R; van Tinteren H; Linn S; Horlings HM; Kok M
    Eur J Cancer; 2020 Mar; 127():240-250. PubMed ID: 31956037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BI-RADS Ultrasound Lexicon Descriptors and Stromal Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
    Candelaria RP; Spak DA; Rauch GM; Huo L; Bassett RL; Santiago L; Scoggins ME; Guirguis MS; Patel MM; Whitman GJ; Moulder SL; Thompson AM; Ravenberg EE; White JB; Abuhadra NK; Valero V; Litton J; Adrada BE; Yang WT
    Acad Radiol; 2022 Jan; 29 Suppl 1(Suppl 1):S35-S41. PubMed ID: 34272161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group.
    Van Bockstal MR; Cooks M; Nederlof I; Brinkhuis M; Dutman A; Koopmans M; Kooreman L; van der Vegt B; Verhoog L; Vreuls C; Westenend P; Kok M; van Diest PJ; Nauwelaers I; Laudus N; Denkert C; Rimm D; Siziopikou KP; Ely S; Zardavas D; Roberts M; Floris G; Hartman J; Acs B; Peeters D; Bartlett JMS; Dequeker E; Salgado R; Giudici F; Michiels S; Horlings H; van Deurzen CHM
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stromal Tumor Infiltrating Lymphocytes (sTILs) Were Associated with a Higher Grade and a Lower Stage of Indonesian Triple Negative Breast Cancers.
    Widodo I; Ghozali A; Purwanto I; Ferronika P
    Asian Pac J Cancer Prev; 2022 Aug; 23(8):2749-2754. PubMed ID: 36037130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The importance of stromal and intratumoral tumor lymphocyte infiltration for pathologic complete response in patients with locally advanced breast cancer.
    Eryilmaz MK; Mutlu H; Ünal B; Salim DK; Musri FY; Coşkun HŞ
    J Cancer Res Ther; 2018; 14(3):619-624. PubMed ID: 29893329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group.
    Denkert C; Wienert S; Poterie A; Loibl S; Budczies J; Badve S; Bago-Horvath Z; Bane A; Bedri S; Brock J; Chmielik E; Christgen M; Colpaert C; Demaria S; Van den Eynden G; Floris G; Fox SB; Gao D; Ingold Heppner B; Kim SR; Kos Z; Kreipe HH; Lakhani SR; Penault-Llorca F; Pruneri G; Radosevic-Robin N; Rimm DL; Schnitt SJ; Sinn BV; Sinn P; Sirtaine N; O'Toole SA; Viale G; Van de Vijver K; de Wind R; von Minckwitz G; Klauschen F; Untch M; Fasching PA; Reimer T; Willard-Gallo K; Michiels S; Loi S; Salgado R
    Mod Pathol; 2016 Oct; 29(10):1155-64. PubMed ID: 27363491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of tumor-infiltrating lymphocytes of breast cancer in core needle biopsies and resected specimens: a retrospective analysis.
    Cha YJ; Ahn SG; Bae SJ; Yoon CI; Seo J; Jung WH; Son EJ; Jeong J
    Breast Cancer Res Treat; 2018 Sep; 171(2):295-302. PubMed ID: 29869774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers.
    Loi S; Drubay D; Adams S; Pruneri G; Francis PA; Lacroix-Triki M; Joensuu H; Dieci MV; Badve S; Demaria S; Gray R; Munzone E; Lemonnier J; Sotiriou C; Piccart MJ; Kellokumpu-Lehtinen PL; Vingiani A; Gray K; Andre F; Denkert C; Salgado R; Michiels S
    J Clin Oncol; 2019 Mar; 37(7):559-569. PubMed ID: 30650045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of stromal tumour infiltrating lymphocytes and programmed cell death-ligand 1 expression in breast cancer.
    Polónia A; Pinto R; Cameselle-Teijeiro JF; Schmitt FC; Paredes J
    J Clin Pathol; 2017 Oct; 70(10):860-867. PubMed ID: 28373294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.